Research programme: methionine depletion anticancer therapeutics - DevaCellAlternative Names: methaSHELS
Latest Information Update: 11 Aug 2016
At a glance
- Originator DevaCell
- Class Carbon sulfur lyases; Enzymes
- Mechanism of Action DNA methylation inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Solid tumours
Most Recent Events
- 11 Aug 2016 Early research in Solid tumours in USA (IV)
- 11 Aug 2016 Early research in Solid tumours in USA (IM)